<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/CEBD0459-3618-46C0-981C-734AAAABCE4B"><gtr:id>CEBD0459-3618-46C0-981C-734AAAABCE4B</gtr:id><gtr:name>MRC Mammalian Genetics Unit</gtr:name><gtr:address><gtr:line1>Harwell</gtr:line1><gtr:line4>Didcot</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX11 0RD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CEBD0459-3618-46C0-981C-734AAAABCE4B"><gtr:id>CEBD0459-3618-46C0-981C-734AAAABCE4B</gtr:id><gtr:name>MRC Mammalian Genetics Unit</gtr:name><gtr:address><gtr:line1>Harwell</gtr:line1><gtr:line4>Didcot</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX11 0RD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7CFDFAB9-06D8-43A6-B2A5-74C2A65D669D"><gtr:id>7CFDFAB9-06D8-43A6-B2A5-74C2A65D669D</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Denny</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U142684174"><gtr:id>9428EDF0-B004-4F75-B3EF-BE19786A82B0</gtr:id><gtr:title>Infection Genetics and Functional Genomics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U142684174</gtr:grantReference><gtr:abstractText>Mice are the pre-eminent animal models for human genetics and disease. We are studying the genetics of susceptibility to bacterial infection in mice and using chemically induced mutations to improve our basic biological understanding of gene function in health and disease. The main bacterium we study is Streptococcus pneumoniae, which causes glue ear, pneumonia, and bacterial meningitis in humans; despite vaccine and antibiotic therapies, infections caused by this bacterium may still be deadly.||We construct maps of the mouse genome, supplying different levels of map detail. Some of the maps indicate the general lie of the land, like a physical map, whereas other maps indicate the presence of features such as towns. In this analogy, towns represent the variations in specific genes associated with traits or phenotypes. Our research helps in finding these variations, so that we can then study how they influence susceptibility to bacterial infection.||Almost all mouse genes have a human counterpart and so genes controlling infection in mice are likely to play a similar role in humans. We expect, therefore, to improve our understanding of the basic biology of infection in humans and mice. Furthermore, we may contribute to improvements in prevention and treatment of infection.</gtr:abstractText><gtr:technicalSummary>Our main focus is susceptibility to infection by Streptococcus pneumoniae; an important human pathogen, causing pneumonia and bacterial meningitis, which are associated with very high morbidity and mortality. Streptococcus pneumoniae (the pneumococcus) is the main cause of bacterial pneumonia worldwide and in more than a quarter of cases, the bacteria cross from the lungs into the bloodstream, to become a serious system-wide infection. The bacterium is also a major cause of otitis media, or glue ear, which affects many children under 3 years of age.||These diseases make significant demands on the resources of the NHS: 30% of pneumonia patients require home visits and 10% of admissions to intensive care units are for community acquired pneumonia. Even where appropriate antibiotics are given, the overall fatality rate for pneumococcal disease remains about 20%. Infectious diseases such as pneumonia are influenced strongly by genetic predisposition.||Our aim is to determine the genetic basis of infection susceptibility, providing the possibility of targeting therapy or prophylaxis to those most at risk. Additionally, identification of new mechanisms of disease or resistance to disease that will result, may lead to new therapeutic or prophylactic agents.||We have identified a mouse model for pneumonia and bacteraemia, in collaboration with Prof. Peter Andrew at Leicester University and mapped a major quantitative trait locus (QTL) conferring susceptibility to infection. In order to identify the genetic variant that underlies this locus, we are testing candidate genes for differences in sequence or expression level that might influence their function prior to, or during, infection. The task of selecting candidate genes is being directed by finer genetic mapping using congenic mouse strains.||We are also taking two complementary approaches to identify further infection susceptibility genes; firstly, scanning the mouse genome for other QTL and secondly, testing the offspring of mice treated with ENU for mutant phenotypes related to infection.||Infection susceptibility genes identified in the mouse, or genes predicted to interact in the same biological network, are likely to play a similar role in humans. Through collaboration with Prof. Adrian Hill, Univ. Oxford, we plan to test human homologues of mouse infection susceptibility genes for association with invasive pneumococcal disease.</gtr:technicalSummary><gtr:fund><gtr:end>2009-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1996-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1725451</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School pupils visited MRC Harwell</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D1351699-535A-46DF-9B85-1C764C2247C0</gtr:id><gtr:impact>presentation to school children as part of a day spent at Harwell doing hands-on science.

none</gtr:impact><gtr:outcomeId>24F24D548BA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>58423</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Framework 7</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>B133E9FC-7989-4BE7-96DB-89BE74720E7A</gtr:id><gtr:outcomeId>WDfzk3Y5d8C0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>77A3D7BC-B58E-422F-889C-5FF478314C83</gtr:id><gtr:title>IkappaB genetic polymorphisms and invasive pneumococcal disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83ba0b54ae341fa7ab77ba270097e9ba"><gtr:id>83ba0b54ae341fa7ab77ba270097e9ba</gtr:id><gtr:otherNames>Chapman SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>GyBPxhz5y4B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D637C1DE-4E82-47B2-9835-397CED822917</gtr:id><gtr:title>Lineage-specific biology revealed by a finished genome assembly of the mouse.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/886631b8e3f060e6d5f94887983847da"><gtr:id>886631b8e3f060e6d5f94887983847da</gtr:id><gtr:otherNames>Church DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>B3E366E7B3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F936871-B6B2-46A7-BCCB-E89A49741D31</gtr:id><gtr:title>Myofibrillar myopathy caused by a mutation in the motor domain of mouse MyHC IIb.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae282c81a81f5675529bc5f4f9a7c781"><gtr:id>ae282c81a81f5675529bc5f4f9a7c781</gtr:id><gtr:otherNames>Kurapati R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13902_22_22199023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C705E25-7362-445F-9813-31C7E372A5BF</gtr:id><gtr:title>Spir2; a novel QTL on chromosome 4 contributes to susceptibility to pneumococcal infection in mice.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/078031593144397df99b64f97aa971cc"><gtr:id>078031593144397df99b64f97aa971cc</gtr:id><gtr:otherNames>Wisby L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>pm_13902_22_23577770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D0E2760-003E-45A8-A649-2FA1BD82732D</gtr:id><gtr:title>Macrophages from BALB/c and CBA/Ca mice differ in their cellular responses to Streptococcus pneumoniae.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b8639e5302a8a55d5598d1f9b5a1b85"><gtr:id>7b8639e5302a8a55d5598d1f9b5a1b85</gtr:id><gtr:otherNames>Ripoll VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>YEpHEvoCwMv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DFDBACC-5625-41C7-80E8-00009FCD4760</gtr:id><gtr:title>Genetic factors regulating lung vasculature and immune cell functions associate with resistance to pneumococcal infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/495d40da23a880146303ed45e5f692a0"><gtr:id>495d40da23a880146303ed45e5f692a0</gtr:id><gtr:otherNames>Jonczyk MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5453c7a3e05919.54753067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97CB6237-C96B-4890-81D1-A8C8D7020A9D</gtr:id><gtr:title>Foxf2: a novel locus for anterior segment dysgenesis adjacent to the Foxc1 gene.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27ebb6f56a5223dc0e0312c783d82884"><gtr:id>27ebb6f56a5223dc0e0312c783d82884</gtr:id><gtr:otherNames>McKeone R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>VdYjguxp4mi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9602C0EC-0211-4A76-BBF6-58BF553C0D25</gtr:id><gtr:title>T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a83ce11c46bd184c75e59dcc3d7fd5"><gtr:id>70a83ce11c46bd184c75e59dcc3d7fd5</gtr:id><gtr:otherNames>Neill DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13902_22_22563306</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U142684174</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>